The female dogs with mammary gland tumors (n=106) presented at the small animal clinical complex, Guru Angad Dev Veterinary and Animal Sciences University, Ludhiana, Punjab from different locations of Ludhiana city were studied for prevalence of the disease. Body temperature and respiration rate of tumor bearing bitches were comparable to that of values of healthy dogs but the pulse rate was observed to be significantly (p10 years old). Spitz breed accounted for 39.62% of cases presented followed by German shepherd (31.13%), non-descript (16.98%) and Labrador (12.26%). Bitches from industrial areas are most susceptible to mammary tumors (79.24%). Gross pathological investigation reported that most of the developed tumors (45.28%) affecting first two glands. 79.24% of tumors were palpated to be hard and 20.75% are soft. Nodular type tumors consisted of 74.52% of cases and 49.05% of tumors were observed to be recurrent. Histopathological analysis revealed that 66.03% of tumors were malignant and 33.96% belong to benign group. Most of the tumor affected bitches were in stage III (41.50%). The present study observed that mammary tumor in female dogs is an emerging animal health problem and special attention is needed for its prevention and treatment.
Mammary tumors, female dogs, prevalence
Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay.
Hong KH, In JW, Lee J, Kim SY, Lee KA, Kim S, An Y, Lee D, Sung H, Kim JS, Lee H
Annals of laboratory medicine. 2022; 42(1): 96-99
Meta-Analysis of Proportions.
Schwarzer G, RÃ¼cker G
Methods in molecular biology (Clifton, N.J.). 2022; 2345(): 159-172
Female sex in experimental traumatic brain injury research: forging a path forward.
Currier Thomas T, Bromberg CE, Krishna G
Neural regeneration research. 2022; 17(3): 550-552
Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles.
Lee D, Kwon S, Jang SY, Park E, Lee Y, Koo H
Bioactive materials. 2022; 8(): 20-34
Targeted and intracellular delivery of protein therapeutics by a boronated polymer for the treatment of bone tumors.
Yan Y, Zhou L, Sun Z, Song D, Cheng Y
Bioactive materials. 2022; 7(): 333-340